These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2941493)

  • 1. The effects of long-term administration of recombinant alpha-2 interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosis.
    Hirsch RL; Johnson KP
    J Interferon Res; 1986 Apr; 6(2):171-7. PubMed ID: 2941493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.
    Rudick RA; Carpenter CS; Cookfair DL; Tuohy VK; Ransohoff RM
    Neurology; 1993 Oct; 43(10):2080-7. PubMed ID: 8105424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon beta augments suppressor cell function in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    Ann Neurol; 1990 Feb; 27(2):207-10. PubMed ID: 2138445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    Ann Neurol; 1992 Jan; 31(1):103-6. PubMed ID: 1371908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of interferon-alpha and interferon-gamma receptor expression during T-lymphocyte activation and proliferation.
    Faltynek CR; Princler GL
    J Interferon Res; 1986 Dec; 6(6):639-53. PubMed ID: 2952737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function.
    Tjernlund U; Cesaro P; Tournier E; Degos JD; Bach JF; Bach MA
    Clin Immunol Immunopathol; 1984 Aug; 32(2):185-97. PubMed ID: 6234118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor T cell activation by human leukocyte interferon.
    Schnaper HW; Aune TM; Pierce CW
    J Immunol; 1983 Nov; 131(5):2301-6. PubMed ID: 6226738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulatory role of adenosine activated T-lymphocyte subset on the immune response in humans. II. Adenosine induced expression of T8 antigen.
    Moroz C; Twig S
    Biomed Pharmacother; 1985; 39(3):145-50. PubMed ID: 2933092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2.
    Hirsch RL; Johnson KP
    Clin Immunol Immunopathol; 1985 Nov; 37(2):236-44. PubMed ID: 3899434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function.
    Durelli L; Bongioanni MR; Cavallo R; Ferrero B; Ferri R; Verdun E; Bradac GB; Riva A; Geuna M; Bergamini L
    Mult Scler; 1995; 1 Suppl 1():S32-7. PubMed ID: 9345396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal T cell subsets and lymphocyte activity in multiple sclerosis.
    Albala MM; Davignon D; Fast LD; Clark DD
    Clin Exp Immunol; 1985 Sep; 61(3):542-7. PubMed ID: 3878242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
    Masucci MG; Torsteinsdottir S; Pear W; Carstensen A; Klein E
    J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an anti-IL-10 monoclonal antibody on rIFNbeta-1b-mediated immune modulation. Relevance to multiple sclerosis.
    Porrini AM; De Luca G; Gambi D; Reder AT
    J Neuroimmunol; 1998 Jan; 81(1-2):109-15. PubMed ID: 9521612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity of isolated subsets of human lymphocytes (E+, OKT4+, OKT8+): protective role of monocytes and monokines.
    Manori I; Kushilevsky A; Segal S; Weinstein Y
    Clin Exp Immunol; 1984 Nov; 58(2):453-61. PubMed ID: 6238736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study of immunological status in patients with gastric cancer: with special reference to T-cell subsets, interleukin-2 in the lymphocytes of peripheral blood].
    Owada S
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):52-61. PubMed ID: 2138244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of a human antibody response in vitro mediated by interaction of interferon-alpha with T lymphocytes.
    Evans SS; Ozer H
    J Immunol; 1987 Apr; 138(8):2451-6. PubMed ID: 2951440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OKT3 induces suppressor cells for mixed lymphocyte and PHA mitogenic responses in human peripheral lymphocytes.
    Lau C; Goldstein G
    Int J Immunopharmacol; 1981; 3(3):187-92. PubMed ID: 6457004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
    Hartrich L; Weinstock-Guttman B; Hall D; Badgett D; Baier M; Patrick K; Feichter J; Hong J; Ramanathan M
    J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.